Robotic laparoendoscopic single-site ultrasound-guided renal artery balloon catheter occluded hybrid partial nephrectomy (LESS-HPN): a prospective pilot study
- PMID: 39934736
- PMCID: PMC11818040
- DOI: 10.1186/s12894-025-01711-z
Robotic laparoendoscopic single-site ultrasound-guided renal artery balloon catheter occluded hybrid partial nephrectomy (LESS-HPN): a prospective pilot study
Abstract
Objective: To investigate a novel intracorporeal minimally invasive procedure for robot assisted laparoendoscopic single-site partial nephrectomy.
Methods: This study reported our technique and the outcomes of a minimally invasive approach for partial nephrectomy, specifically robotic laparoendoscopic single-site ultrasound-guided renal artery balloon catheter occluded hybrid partial nephrectomy (LESS-HPN). A Freeport for LESS was inserted through a 4.5-5.0 cm skin incision. Instead of the traditional renal artery clamping technique, a Fogarty balloon catheter was used to occlude the renal artery or its branch. Tumor resection and wound suturing was then performed as routine steps.
Results: A total of 10 patients with T1 stage renal tumors underwent successful LESS-HPN from March to July 2023, with no conversions to renal artery clamping or additional ports. The mean operative time was 103.3 ± 11.1 min, including 21.0 ± 2.7 min of warm ischemia time. The mean estimated blood loss was 42.0 ± 22.5 ml. Tumors located posteriorly were associated with shorter operative time compared to those located anteriorly (p = 0.041). Occlusion of the main renal arteries, branch arteries, and accessory renal artery was achieved in 7, 2 and 1 cases, respectively. During a median follow-up of 10.5 months, no recurrence, metastasis, or death was observed. Limitations of this study include the small sample size, the absence of a control group, and the relatively short follow-up duration.
Conclusions: LESS-HPN has proven to be a safe and feasible alternative for achieving intracorporeal minimal invasiveness in patients with renal tumors.
Trial registration: Clinical trials were registered in September 4th, 2021, available at www.chictr.org.cn/ (ChiCTR2100050808). This article belongs to a selection of patients who were part of this clinical study.
Keywords: Hybrid partial nephrectomy; Laparoscopic ultrasound; Pilot study; Robotic laparoendoscopic single-site.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The ethics committee of Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology approved this study (No. 2020S138). Informed consent to participate was obtained from all of the participants in the study. Our study adhered to the Declaration of Helsinki. Consent for publication: All authors consent to publication. Competing interests: The authors declare no competing interests.
Figures


References
-
- Dobbs RW, Magnan BP, Abhyankar N, Hemal AK, Challacombe B, Hu J, et al. Cost effectiveness and robot-assisted urologic surgery: does it make dollars and sense? Minerva Urol Nefrol. 2017;69(4):313–23. - PubMed
-
- Casale P, Lughezzani G, Buffi N, Larcher A, Porter J, Mottrie A, et al. Evolution of Robot-assisted partial nephrectomy: techniques and outcomes from the Transatlantic Robotic Nephron-sparing surgery Study Group. Eur Urol. 2019;76(2):222–7. - PubMed
-
- Kommu SS, Kaouk JH, Rane A. Laparo-endoscopic single-site surgery: preliminary advances in renal surgery. BJU Int. 2009;103(8):1034–7. - PubMed
-
- Park SK, Olweny EO, Best SL, Tracy CR, Mir SA, Cadeddu JA. Patient-reported body image and cosmesis outcomes following kidney surgery: comparison of laparoendoscopic single-site, laparoscopic, and open surgery. Eur Urol. 2011;60(5):1097–104. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical